Ronald C. Davidson

Ronald C. Davidson, professor of physics at Massachusetts Institute of Technology since 1978, has been named director of the Princeton Plasma Physics Laboratory (PPPL). Funded by the United States Department of Energy, PPPL operates on an annual budget of nearly $100 million. Research at the laboratory focuses on the creation of energy from the fusion of hydrogen nuclei confined by magnetic fields. Davidson's new position began on January 1. Davidson joined the physics faculty of MIT in 1978,

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Ronald C. Davidson, professor of physics at Massachusetts Institute of Technology since 1978, has been named director of the Princeton Plasma Physics Laboratory (PPPL). Funded by the United States Department of Energy, PPPL operates on an annual budget of nearly $100 million. Research at the laboratory focuses on the creation of energy from the fusion of hydrogen nuclei confined by magnetic fields. Davidson's new position began on January 1.

Davidson joined the physics faculty of MIT in 1978, and directed MIT's Plasma Fusion Center from 1978 to 1988. He has made fundamental theoretical contributions to several areas of pure and applied plasma physics, including nonlinear plasma theory, nonneutral plasma theory, and advanced accelerator concepts.

Davidson earned his Ph.D. at Princeton University in 1966. >From 1968 until joining MIT, he taught physics at the University of Maryland at College Park. In 1974 and 1975, Davidson was visiting senior scientist at Los ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies